When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 06 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • history of prior pelvic surgery
  • irregular menstrual cycles
  • hirsutism
  • acne
  • palpable uterine abnormalities
  • adnexal abnormalities
  • galactorrhoea

Other diagnostic factors

  • dyspareunia
  • cul de sac abnormalities

Risk factors

  • age >35 years
  • history of sexually transmitted infection
  • very high body fat
  • very low body fat
  • cigarette smoking
  • auto-immune disease
  • history of appendicitis
  • history of caesarean or instrumental vaginal delivery
  • psychiatric disease
  • substance misuse
  • alcohol consumption
  • caffeine consumption
  • occupational or environmental exposures
  • stress

Diagnostic investigations

1st investigations to order

  • semen analysis
  • luteal-phase progesterone
  • urinary luteinising hormone (LH)
  • transvaginal ultrasound scan
  • chlamydia antibody testing
  • hysterosalpingogram
  • hysterosalpingo-contrast sonography (HyCosY)
  • basal follicle-stimulating hormone (FSH)
  • saline infusion sonogram
  • antral follicle count
  • serum anti-Müllerian hormone (AMH)

Investigations to consider

  • serum LH
  • serum oestradiol
  • free serum testosterone
  • serum TSH
  • coeliac disease testing
  • serum prolactin
  • 3-dimensional ultrasonography
  • pelvic MRI
  • laparoscopy and hysteroscopy
  • karyotyping

Treatment algorithm

Contributors

Authors

Andrew Drakeley, MBChB, MD, FRCOG

Consultant Gynaecologist

Hewitt Fertility Centre

Liverpool Women's Hospital

Liverpool

UK

Disclosures

AD is Director and stock holder of IVF 2.0 and Horizon Fertility. AD is an advisor to TMRW Life Sciences and Cambridge Clinical Laboratories, and has received conference attendance support from Ferring, Merck, IBSA, and Theramex Pharma.

Lewis Nancarrow, MD, MRCOG

Subspecialty Trainee in Reproductive Medicine

Hewitt Fertility Centre

Liverpool Women's NHS Foundation Trust

Liverpool

UK

Disclosures

LN has been reimbursed for conference attendances by Ferring and for presenting at a fertility nurses conference by IBSA.

Acknowledgements

Dr Andrew Drakeley and Dr Dr Lewis Nancarrow would like to gratefully acknowledge Dr Daphne Chong, Dr Jane A. Stewart, and Dr Jared C. Robins, previous contributors to this topic.

Disclosures

DC declares that she has no competing interests. JAS is a past Chair of the British Fertility Society; she is also the head of a large NHS fertility service. JCR declares that he has no competing interests.

Peer reviewers

Daniel Williams, MD

Professor of Clinical Obstetrics and Gynecology

University of Cincinnati College of Medicine

Cincinnati

OH

Disclosures

DW declares that he has no competing interests.

Mira Aubuchon, MD

Assistant Clinical Professor

Division of Reproductive Endocrinology

University College of Medicine

Cincinnati

OH

Disclosures

MA declares that she has no competing interests.

Stephanie Dahl, MD

Assistant Clinical Professor

Department of Obstetrics and Gynecology

University of North Dakota School of Medicine

Fargo

ND

Disclosures

SD declares that she has no competing interests.

Use of this content is subject to our disclaimer